| scholarly article | Q13442814 |
| P356 | DOI | 10.1176/APPI.AJP.158.6.872 |
| P698 | PubMed publication ID | 11384893 |
| P50 | author | Sergio E. Starkstein | Q67207556 |
| P2093 | author name string | Chemerinski E | |
| Kremer J | |||
| Petracca G | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 872-877 | |
| P577 | publication date | 2001-06-01 | |
| P1433 | published in | American Journal of Psychiatry | Q1935368 |
| P1476 | title | Syndromic validity of apathy in Alzheimer's disease. | |
| P478 | volume | 158 |
| Q40101058 | A Novel Assessment and Profiling of Multidimensional Apathy in Alzheimer's Disease |
| Q38127104 | A multidimensional approach to apathy after traumatic brain injury |
| Q36226248 | A prospective longitudinal study of apathy in Alzheimer's disease |
| Q38134345 | A review of current information and communication technologies: can they be used to assess apathy? |
| Q33862404 | A review of neuroimaging findings of apathy in Alzheimer's disease |
| Q93145626 | A survey on the prevalence of apathy in elderly people referred to specialized memory centers |
| Q48272246 | A systematic review of non-pharmacological treatments for apathy in dementia |
| Q42675514 | Acute treatment with bis selenide, an organic compound containing the trace element selenium, prevents memory deficits induced by reserpine in rats |
| Q43188758 | Anosognosia in people with cognitive impairment: association with cognitive deficits and behavioral disturbances |
| Q47634319 | Apathetic symptom presentations in patients with severe traumatic brain injury: Assessment, heterogeneity and relationships with psychosocial functioning and caregivers' burden |
| Q33945607 | Apathy and cognitive and functional decline in community-dwelling older adults: results from the Baltimore ECA longitudinal study |
| Q46596394 | Apathy and cognitive performance in older adults with depression |
| Q36587244 | Apathy and cognitive test performance in patients undergoing cardiac testing |
| Q42616918 | Apathy and depressive mood in nursing home patients with early-onset dementia |
| Q37551892 | Apathy and intrinsic functional connectivity networks in amnestic mild cognitive impairment |
| Q28484820 | Apathy and white matter integrity in Alzheimer's disease: a whole brain analysis with tract-based spatial statistics |
| Q37764378 | Apathy following stroke |
| Q38391306 | Apathy in Neurodegenerative Diseases: Recommendations on the Design of Clinical Trials |
| Q39966924 | Apathy in Older Persons With Depression: Course and Predictors: The NESDO Study |
| Q46117576 | Apathy in elderly nondemented patients with Parkinson's disease: clinical determinants and relationship to quality of life |
| Q37754067 | Apathy in neuropsychiatric disease: diagnosis, pathophysiology, and treatment |
| Q51947461 | Apathy in schizophrenia: clinical correlates and association with functional outcome. |
| Q33663500 | Apathy, but not depression, is associated with executive dysfunction in cerebral small vessel disease |
| Q47320840 | Apathy, not depressive symptoms, as a predictor of semantic and phonemic fluency task performance in stroke and transient ischemic attack |
| Q38616633 | Apathy: a practical guide for neurologists |
| Q34987695 | Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine. |
| Q37518104 | Are the available apathy measures reliable and valid? A review of the psychometric evidence |
| Q42125129 | Aripiprazole for Treatment of Apathy |
| Q59660127 | Aspects cliniques et neurophysiologiques de la dépression et de l’apathie |
| Q35635954 | Assessing and predicting functional impairment in Alzheimer's disease: the emerging role of frontal system dysfunction |
| Q47808180 | Assessing apathy in long-term care residents with dementia: Who should be the rater? |
| Q34786763 | Assessment of late life depression. |
| Q36197770 | Awareness in dementia: a review of clinical correlates |
| Q51912963 | Behavioral disturbances in the course of frontotemporal dementia. |
| Q92584394 | Brain Perfusion Correlates of Apathy in Alzheimer's Disease |
| Q45807596 | Brazilian caregiver version of the Apathy Scale |
| Q34112057 | Cardiopulmonary exercise testing is well tolerated in people with Alzheimer-related cognitive impairment |
| Q50910422 | Characteristics of apathy in Parkinson's disease. |
| Q48748275 | Characterizing behavioral and cognitive dysexecutive changes in progressive supranuclear palsy |
| Q41017873 | Clinically significant psychiatric symptoms among male carriers of the fragile X premutation, with and without FXTAS, and the mediating influence of executive functioning |
| Q39340473 | Collaborative research between academia and industry using a large clinical trial database: a case study in Alzheimer's disease |
| Q39401622 | Complaints of informal caregivers providing home care for dementia patients: the Pixel study |
| Q42615799 | Computerized assessment of goal-directed behavior in Parkinson's disease |
| Q98623174 | Cortical thickness abnormalities in long-term remitted Cushing's disease |
| Q42651686 | Decreased initiation of usual activities in people with mild-to-moderate Alzheimer's disease: a descriptive analysis from the VISTA clinical trial |
| Q48421810 | Depression and apathy affect functioning in community active subjects with questionable dementia and mild Alzheimer's disease |
| Q35189671 | Depression in Alzheimer's disease: heterogeneity and related issues |
| Q39273337 | Depressive symptoms in late life: associations with apathy, resilience and disability vary between young-old and old-old |
| Q36109984 | Designing a trial to evaluate potential treatments for apathy in dementia: the apathy in dementia methylphenidate trial (ADMET). |
| Q45017995 | Diagnostic criteria for apathy in clinical practice. |
| Q47283680 | Diagnostic criteria for depression in Parkinson's disease: a study of symptom patterns using latent class analysis |
| Q42176761 | Dopamine pathway loss in nucleus accumbens and ventral tegmental area predicts apathetic behavior in MPTP-lesioned monkeys. |
| Q48557160 | Down and drowsy? Do apathetic nursing home residents experience low quality of life? |
| Q35089933 | Dysthymia and apathy: diagnosis and treatment |
| Q50683216 | Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease. |
| Q36894251 | Epidemiology and management of apathy in patients with Alzheimer's disease |
| Q47832160 | Evaluation of a pet-assisted living intervention for improving functional status in assisted living residents with mild to moderate cognitive impairment: a pilot study |
| Q34610660 | Examination of the Lille Apathy Rating Scale in Parkinson disease |
| Q37619421 | Exploring social cognition in patients with apathy following acquired brain damage |
| Q50583177 | Facial expression in Alzheimer's disease: impact of cognitive deficits and neuropsychiatric symptoms. |
| Q48118523 | Factors associated with increased caregivers' burden in several cognitive stages of Alzheimer's disease |
| Q34641123 | Geriatric depression and cognitive impairment |
| Q45401670 | Imaging apathy in Alzheimer's disease |
| Q48439664 | Lack of initiative and interest in Alzheimer's disease: a single photon emission computed tomography study |
| Q40065394 | Latent class analysis of the Apathy Scale does not identify subtypes of apathy in general population-based older persons |
| Q41324424 | Longitudinal Neuropsychiatric Predictors of Death in Alzheimer's Disease |
| Q37401319 | Longitudinal change in everyday function and behavioral symptoms in frontotemporal dementia |
| Q43879622 | More insight into the concept of apathy: a multidisciplinary depression management program has different effects on depressive symptoms and apathy in nursing homes |
| Q47723170 | Negative symptoms in Alzheimer's disease: a confirmatory factor analysis |
| Q33790185 | Neural basis of self-initiative in relation to apathy in a student sample. |
| Q46773027 | Neural correlates of anosognosia for cognitive impairment in Alzheimer's disease |
| Q46964070 | Neural correlates of apathy revealed by lesion mapping in participants with traumatic brain injuries |
| Q48469555 | Neuropsychiatric symptoms of dementia: cross-sectional analysis from a prospective, longitudinal Belgian study |
| Q50736786 | Neuropsychological patterns underlying anosognosia in people with cognitive impairment. |
| Q48460169 | Neuropsychological performance in mild cognitive impairment with and without apathy |
| Q57743179 | Neuroscience of apathy and anhedonia: a transdiagnostic approach |
| Q48248458 | Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer's disease and mild cognitive impairment subtypes |
| Q35489501 | On the overlap between apathy and depression in dementia. |
| Q38170594 | On the relation among mood, apathy, and anosognosia in Alzheimer's disease. |
| Q38456151 | Parkinson's disease: a review of non-motor symptoms. |
| Q39886807 | Patterns and persistence of behavioural and psychological symptoms in those with cognitive impairment: the importance of apathy |
| Q38985928 | Pharmacological Therapy for Apathy in Alzheimer's Disease: A Systematic Review and Meta-Analysis |
| Q34552380 | Pharmacological and Nonpharmacological Treatment for Apathy in Alzheimer Disease : A systematic review across modalities |
| Q38592071 | Phenomenology of Depression in Alzheimer's Disease |
| Q38401904 | Post-stroke dementia and depression: frontosubcortical dysfunction as missing link? |
| Q34759338 | Predictors of early post ischemic stroke apathy and depression: a cross-sectional study |
| Q28109662 | Prefrontal Activity and Connectivity with the Basal Ganglia during Performance of Complex Cognitive Tasks Is Associated with Apathy in Healthy Subjects |
| Q58786306 | Preliminary evidence for an increased likelihood of a stable trajectory in mild cognitive impairment in individuals with higher motivational abilities |
| Q26783293 | Psychiatric aspects of brain tumors: A review |
| Q37915669 | Psychiatric complications of dementia |
| Q38717457 | Psychometric testing of a Swedish version of the Apathy Evaluation Scale. |
| Q33496593 | Quality of life as an outcome in Alzheimer's disease and other dementias--obstacles and goals |
| Q37719730 | REVIEW: Apathy diagnosis, assessment, and treatment in Alzheimer's disease |
| Q48477558 | Relationship between apathy and diffusion tensor imaging metrics of the brain in Alzheimer's disease |
| Q45181271 | Relationship between cognition and awareness of deficit in mild cognitive impairment |
| Q59662456 | Reliability of the Brazilian Portuguese version of the Neuropsychiatric Inventory (NPI) for patients with Alzheimer's disease and their caregivers |
| Q36552900 | Research agenda for DSM-V: diagnostic categories and criteria for neuropsychiatric syndromes in dementia |
| Q36821767 | Resting-State Functional Connectivity in Patients with Long-Term Remission of Cushing's Disease |
| Q57142315 | Self- and informant-rated apathy in patients with childhood-onset craniopharyngioma |
| Q37230619 | Self-awareness and self-monitoring of cognitive and behavioral deficits in behavioral variant frontotemporal dementia, primary progressive aphasia and probable Alzheimer's disease |
| Q47131749 | Serum levels of soluble TNF-α receptors but not BDNF are associated with apathy symptoms in mild Alzheimer's disease and amnestic mild cognitive impairment |
| Q34324704 | Social adaptive functioning, apathy, and nondysphoric depression among nursing home-dwelling very old adults |
| Q50755328 | Stereotypic behaviors in degenerative dementias. |
| Q47590697 | Symptoms of apathy are associated with progression from mild cognitive impairment to Alzheimer's disease in non-depressed subjects |
| Q33761420 | The Brief Psychiatric Rating Scale (version 4.0) factorial structure and its sensitivity in the treatment of outpatients with unipolar depression |
| Q36226345 | The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease |
| Q48613369 | The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. |
| Q88931329 | The course of apathy in late-life depression treated with electroconvulsive therapy; a prospective cohort study |
| Q91174246 | The impact of apathy on cognitive performance in the elderly |
| Q33614473 | The independent contributions of cognitive impairment and neuropsychiatric symptoms to everyday function in older adults |
| Q37766266 | The role of dopamine in symptoms and treatment of apathy in Alzheimer's disease. |
| Q51869791 | The syndromal validity and nosological position of apathy in Parkinson's disease. |
| Q26781597 | The translational study of apathy-an ecological approach |
| Q36282272 | Treatment approaches to symptoms associated with frontotemporal degeneration |
| Q36331459 | Unawareness of deficits in Alzheimer's disease and other dementias: operational definitions and empirical findings |
| Q51017551 | Unawareness of deficits in Alzheimer's disease: role of the cingulate cortex. |
| Q47988586 | Validation of apathy evaluation scale and assessment of severity of apathy in Alzheimer's disease |
| Q37217602 | Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study |
| Q37445941 | Vascular risk factors and neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study |
| Q34804073 | Voxel-based analysis of fractional anisotropy in post-stroke apathy |
| Q33741321 | Widespread reductions of white matter integrity in patients with long-term remission of Cushing's disease |
| Q84054821 | [Apathy in Parkinson's disease] |
| Q81709648 | [The Heidelberg instrument for the assessment of quality of life in dementia (H. I. L. DE.)--dimensions of quality of life and methods of organization] |
Search more.